C. difficile ToxA (aa 1800-2700) Specific Neutra™ Antibody (V3S-0324-FY27), Mouse IgG2a kappa (CAT#: V3S-1022-YC1396)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This antibody demonstrates neutralizing properties against toxin A by effectively recognizing all toxin A repeat domains with a high affinity (KD<30 nM). Its mechanism of action involves neutralizing the toxin by inhibiting its binding to cell surfaces.
Clonality Monoclonal
Host Species Mouse
Target Species C. difficile
Immunogen A fragment of toxin A encompassing the full CWB domain.
Epitope Amino acids 1800-2700
Neutralization Mechanism The most neutralizing monoclonal antibody did not abrogate CWB-domain association with CHO cell surfaces, but retarded the internalization or reorganization of the toxin at the cell surface.
Affinity KD = 0.3 nM
Isotype Mouse IgG2a, kappa

Property

Expression Species HEK293F or CHO Cell line
Conjugation Unconjugated, also available for Biotin, HRP, FITC and PE-labeled form.
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Purified with Protein A or G affinity chromatography
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; Neut
Application Notes Neut: 0.2 μg/mL

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target C. difficile ToxA
Alternative Name C. difficile ToxA
Research Area Cell Biology
Related Disease Bacterial disease
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry